Rockefeller Capital Management L.P. lowered its position in BlackRock Capital Allocation Term Trust (NYSE:BCAT – Free Report) by 7.2% in the 4th quarter, HoldingsChannel reports. The institutional investor owned 429,375 shares of the company’s stock after selling 33,465 shares during the quarter. Rockefeller Capital Management L.P.’s holdings in BlackRock Capital Allocation Term Trust were worth $6,080,000 at the end of the most recent reporting period.
Other institutional investors and hedge funds have also bought and sold shares of the company. Absolute Investment Advisers LLC purchased a new position in shares of BlackRock Capital Allocation Term Trust in the fourth quarter valued at about $5,083,000. Wolverine Asset Management LLC purchased a new stake in shares of BlackRock Capital Allocation Term Trust during the fourth quarter worth about $2,565,000. Closed End Fund Advisors Inc. bought a new stake in BlackRock Capital Allocation Term Trust during the 4th quarter valued at approximately $519,000. Lido Advisors LLC lifted its holdings in BlackRock Capital Allocation Term Trust by 1,243.1% in the 4th quarter. Lido Advisors LLC now owns 180,590 shares of the company’s stock worth $2,566,000 after purchasing an additional 167,144 shares in the last quarter. Finally, Global Retirement Partners LLC boosted its stake in BlackRock Capital Allocation Term Trust by 1,856.5% in the 4th quarter. Global Retirement Partners LLC now owns 8,687 shares of the company’s stock worth $123,000 after purchasing an additional 8,243 shares during the period. 36.12% of the stock is owned by institutional investors.
BlackRock Capital Allocation Term Trust Stock Up 0.3%
Shares of BCAT opened at $15.80 on Friday. BlackRock Capital Allocation Term Trust has a 1 year low of $13.73 and a 1 year high of $16.05. The company has a 50 day simple moving average of $15.48 and a two-hundred day simple moving average of $14.93.
BlackRock Capital Allocation Term Trust Dividend Announcement
About BlackRock Capital Allocation Term Trust
BlackRock Capital Allocation Term Trust (NYSE: BCAT) is a closed-end, diversified management investment company organized as a term trust. The fund’s primary objective is to deliver high current income and total return by investing across a broad range of credit and equity markets. BCAT seeks to achieve this objective through a portfolio of corporate debt securities, floating-rate loans, convertible securities, common and preferred equity, and asset-backed securities.
BCAT employs an actively managed, multi-sector credit approach that spans investment-grade and below-investment-grade bonds, senior secured loans and structured credit.
Further Reading
- Five stocks we like better than BlackRock Capital Allocation Term Trust
- Rocket Lab’s NASA Win Tests Key Support After Sharp Pullback
- AST SpaceMobile Just Nailed a Major Launch—So Why Is the Stock Crashing?
- Palantir’s Valuation Problem Just Met 2 New Growth Catalysts
- Xcel Energy Stock Offers Stability as Electricity Demand Builds
Want to see what other hedge funds are holding BCAT? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for BlackRock Capital Allocation Term Trust (NYSE:BCAT – Free Report).
Receive News & Ratings for BlackRock Capital Allocation Term Trust Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for BlackRock Capital Allocation Term Trust and related companies with MarketBeat.com's FREE daily email newsletter.
